Treatment of Temporomandibular Disorders

NCT01187316 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2010-08-25

No results posted yet for this study

Summary

The aim of the present study was to carry out a pilot project comparing the effectiveness of two therapeutic approaches to temporomandibular disorders (TMDs) in adolescents. Eight female individuals diagnosed based on the Research Diagnosis Criteria for TMDs (RDC/TMD-axis 1)were randomly divided into two groups: 1) Massage therapy and muscle stretching (n=4); and 2) transcutaneous electrical nerve stimulation (TENS) (n=4). Regardless the treatment, ten sessions were held for each patient and two measurements (baseline and 10th session) were performed for the assessment of symptom evolution using a visual analog scale (VAS), maximum opening of the mouth (MOM) and pressure pain threshold (PPT). Statistical analysis wiil be carefully selected.

Conditions

  • Temporomandibular Joint Disorders

Interventions

DEVICE

Transcutaneous electrical nerve stimulation

Sensors were positioned on anterior temporal and masseter muscles bilaterally, and the stimulation was used for 20 minutes at 150 Hz and 100 µs of pulse width; intensity was adjusted individually.

OTHER

Physiotherapy

Massage and stretching of the anterior temporal and masseter muscle were performed by an experienced professional for 20 minutes.

Sponsors & Collaborators

  • University of Pernambuco

    lead OTHER

Principal Investigators

  • Arnaldo F Caldas Junior, PhD · University of Pernambuco

  • Silvia D Benevides, Ms · Federal University of Bahia

  • Mauricio Kosminsky, PhD · University of Pernambuco

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
24 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2007-08-31
Completion
2007-09-30

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01187316 on ClinicalTrials.gov